Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for angiogenesis inhibitors (compound)
Most Correlated Studies
- A549 lung adenocarcinoma cell expression profiling in response to the telomerase inhibitor TMPyP4
- Hepatocellular carcinoma gene expression in primary human tumors and mouse xenografts
- Broad Connectivity Map (CMAP 2.0) compound database
- Expression data from human PBMC samples exposed to IL-12 and paired controls
- Th1 or Th2 in the presence or absence of TGFbeta
Most Relevant Literature
- Efficacy and safety of angiogenesis inhibitors in melanoma: a meta-analysis of seven randomized cont…
- Angiogenesis inhibitors: mechanism of action and nephrotoxicity].
- Discovery of novel PROTACs based on multi-targeted angiogenesis inhibitors.
- Angiogenesis inhibitors for the treatment of epithelial ovarian cancer.
- The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis.
Most Relevant Clinical Trials
- Angiogenesis Inhibitors and Hypertension: Clinical Aspects
- Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
- Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in…
- Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer
- Study of Apatinib as an Inhibitor of Tumor Angiogenesis
